纳米颗粒
化学
锌
药品
抗癌药
没食子酸丙酯
没食子酸
核化学
药理学
纳米技术
生物化学
材料科学
有机化学
抗氧化剂
生物
作者
Pawatsanai Samutprasert,Khajeelak Chiablaem,Chanon Teeraseranee,Punnawich Phaiyarin,Puttikorn Pukfukdee,Prompong Pienpinijtham,Jisnuson Svasti,Tanapat Palaga,Kriengsak Lirdprapamongkol,Supason Pattanaargson Wanichwecharungruang
出处
期刊:RSC Advances
[Royal Society of Chemistry]
日期:2018-02-14
卷期号:8 (14): 7369-7376
被引量:28
摘要
Decreased uptake and cellular accumulation of zinc is a common characteristic in cancer of the liver, pancreas and prostate, because these malignant cells are intolerant to the physiological concentrations of zinc. A tea polyphenol, epigallocatechin-3-gallate (EGCG), can enhance the cytotoxicity of zinc ions to cancer, but the application of this is limited by the low stability of EGCG. In this work, we have prepared a material that can simultaneously preserve the EGCG stability and facilitate zinc uptake and accumulation in cancer cells, under conditions that are not harmful to normal cells. Thus, we co-crystallize zinc oxide with EGCG to obtain hybrid EGCG-ZnO crystalline nanoparticles of 16.5 ± 5.3 nm in diameter. The EGCG-ZnO particles effectively kill PC-3 prostate adenocarcinoma cells at concentrations that are not cytotoxic to normal cells, WI-38 human embryonic lung fibroblasts. The EGCG-ZnO particles are two times more cytotoxic against PC-3 cells than the standard ZnO particles. In PC-3 cells, the EGCG-ZnO particles are taken up by endocytosis, followed by lysosomal disruption to release zinc and EGCG into the cytoplasm, finally resulting in nuclear accumulation of zinc.
科研通智能强力驱动
Strongly Powered by AbleSci AI